Scaling for size: some implications for paediatric anaesthesia dosing
2002; Wiley; Volume: 12; Issue: 3 Linguagem: Inglês
10.1046/j.1460-9592.2002.00616.x
ISSN1460-9592
Autores Tópico(s)Pharmaceutical studies and practices
ResumoPediatric AnesthesiaVolume 12, Issue 3 p. 205-219 Scaling for size: some implications for paediatric anaesthesia dosing Brian J. Anderson Fanzca, Fficanzca, Brian J. Anderson Fanzca, Fficanzca Departments of Anaesthesia and Intensive Care, Auckland Children's Hospital, Auckland, New Zealand,Search for more papers by this authorGeorge H. Meakin MD, FRCA, George H. Meakin MD, FRCA Department of Anaesthesia, Royal Manchester Children's Hospital, Pendlebury, Manchester, UKSearch for more papers by this author Brian J. Anderson Fanzca, Fficanzca, Brian J. Anderson Fanzca, Fficanzca Departments of Anaesthesia and Intensive Care, Auckland Children's Hospital, Auckland, New Zealand,Search for more papers by this authorGeorge H. Meakin MD, FRCA, George H. Meakin MD, FRCA Department of Anaesthesia, Royal Manchester Children's Hospital, Pendlebury, Manchester, UKSearch for more papers by this author First published: 20 March 2002 https://doi.org/10.1046/j.1460-9592.2002.00616.xCitations: 158 B.J. Anderson PICU, Auckland Children's Hospital, Park Road, Grafton, Auckland, New Zealand. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Box GE. The Collected Works of GEP Box. Belmont, CA: Wadsworth Advanced Books and Software; 1985. 2 Dawson WT. Relations between age and weight and dosages of drugs. Ann Intern Med 1940; 13 : 1594–1613. 3 Curran WI, Beecher HK. Experimentation in children: a re-examination of legal and ethical principles. JAMA 1969; 10 : 77–83. 4 Meakin G. Role of propofol in paediatric anaesthetic practice. Paed Anaesth 1995 5 : 147–149. 5 Shirkey H. Therapeutic orphans. J Pediatr 1968; 72 : 119–120. 6 Conroy S. Survey of unlicensed and off-label drug use in paediatric wards in European Countries. Brit Med J 2000; 320 : 79–82. 7 Boxenbaum H. Pharmacokinetics: philosophy of modeling. Drug Metab Rev 1992; 24 : 89–120. 8 Boxenbaum H. Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug Metab Rev 1984; 15 : 1071–1121. 9 Mordenti J. Man versus beast: pharmacokinetic scaling in mammals. J Pharm Sci 1986; 75 : 1028–1040. 10 Boxenbaum H, DiLea C. First-time-in-human dose selection: allometric thoughts and perspectives. J Clin Pharmacol 1995; 35 : 957–966. 11 Reilly JJ, Workman P. Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? A review of theoretical and practical considerations. Cancer Chemother Pharmacol 1993; 32 : 411–418. 12 Crawford JD, Terry ME, Rourke GM. Simplification of drug dosage calculation by application of the surface area principle. Pediatrics 1950; 5 : 783–790. 13 British National Formulary. London: British Medical Association; 1995. 14 Martindale. The Extra Pharmacopoeia. London: The Pharmaceutical Press; 1989. 15 Catzel P, Olver R. Paediatric Prescriber. Oxford: Blackwell; 1981. 16 Lack JA, Stuart Taylor ME. Calculation of drug dosage and body surface area of children. Br J Anaesth 1997; 78 : 601–605. 17 Holford NHG. A size standard for pharmacokinetics. Clin Pharmacokinet 1996; 30 : 329–332. 18 Peters HP. Physiological correlates of size. In: Beck E, Birks HJB, Conner EF, eds. The Ecological Implications of Body Size. Cambridge: Cambridge University Press; 1983: 48–53. 19 Boxenbaum H. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J Pharmacokinet Biopharm 1982; 10 : 201–227. 20 Ritschel WA, Vachharajani NN, Johnson RD et al. The allometric approach for interspecies scaling of pharmacokinetic parameters. Comp Biochem Physiol C 1992; 103 : 249–253. 21 Ritchel WA. Handbook of Basic Pharmacokinetics, 2nd edn. Hamilton, IL: Drug Intelligence Publications; 1980. 22 Brody S, Proctor RC, Ashworth US. Basal metabolism, endogenous nitrogen, creatinine, and sulphur excretions as functions of body weight. Univ Mo Agric Exp Sta Res Bull 1934; 220 : 1–40. 23 Kleiber M. Body size and metabolism. Hilgardia 1932; 6 : 315–333. 24 Stahl WR. Scaling of respiratory variables in mammals. J Appl Physiol 1967; 22 : 453–600. 25 Kleiber M. The Fire of Life: An Introduction to Animal Energetics. New York: Wiley; 1961. 26 McMahon TA. Size and shape in biology. Science 1973; 179 : 1201–1204. 27 West GB, Brown JH, Enquist BJ. A general model for the origin of allometric scaling laws in biology. Science 1997; 276 : 122–126. 28 West GB, Brown JH, Enquist BJ. The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 1999; 284 : 1677–1679. 29 Adolph EF. Quantitative relations in the physiological constitutions of animals. Science 1949; 109 : 579–585. 30 Guyton AC. Measurement of the respiratory volumes of laboratory animals. Am J Physiol 1947; 150 : 70–77. 31 Prothero JW. Scaling of blood parameters in animals. Comp Biochem Physiol 1980; A67 : 649–657. 32 Mahmood I. Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestions. J Pharm Pharmacol 1998; 50 : 493–499. 33 Holford NHG, Anderson BJ. Paediatric dosages. New Ethicals Catalogue. Auckland: Adis International, 1997: C9. 34 Gronert GA, Fung DL, Jones JH et al. Allometry of pharmacokinetics and pharmacodynamics of the muscle relaxant metocurine in mammals. Am J Physiol 1995; 268 : R85–R91. 35 Dedrick RL, Bishoff KB, Zaharko DZ. Interspecies correlation of plasma concentration history of methotrexate. Cancer Chemother Rep Part I 1970; 54 : 95–101. 36 Du Bois D, Du Bois EF. Clinical calorimetry: tenth paper. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17 : 863–871. 37 Williams N. Fractal geometry gets the measure of life's scales. Science 1997; 276 : 3434. 38 Anderson BJ, Ellis JF. Common errors of drug administration in infants: causes and avoidance. Paediatr Drugs 1999; 1 : 93–107. 39 Mitchell D, Strydon NB, Van Graun CH et al. Human surface area: comparison of the dubois formula with direct photometric measurement. Pfugers Arch 1971; 325 : 188–190. 40 Schmidt-Nielsen K. Scaling: Why Is Animal Size So Important? Cambridge: Cambridge University Press; 1984. 41 Friis-Hansen B. The extracellular fluid volume in infants and children. Acta Paediatr 1954; 43 : 444–458. 42 Calder WA, Braun EJ. Scaling of osmotic regulation in mammals and birds. Am J Physiol 1983; 244 : R601–R606. 43 Richmond CR, Langham WH, Trujillo TT. Comparative metabolism of titrated water by mamals. J Cell Comp Physiol 1962; 59 : 45–55. 44 Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I. Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Clin Pharmacokinet 1995; 29 : 257–286. 45 Leff RD, Fischer LJ, Roberts RJ. Phenytoin metabolism in infants following intravenous and oral administration. Dev Pharmacol Ther 1986; 9 : 217–223. 46 Prothero JW. Organ scaling in mammals: the liver. Comp Biochem Physiol A 1982; 71 : 567–577. 47 Mahmood I, Balian JD. Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. Xenobiotica 1996; 26 : 887–895. 48 Vickers MD, Wood-Smith FG, Stewart HC. Drugs in Anaesthetic Practice, 5th edn. London: Butterworths; 1979. 49 Gauntlett IS, Fisher DM, Hertzka RE et al. Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age. Anesthesiology 1988; 69 : 683–687. 50 Yaster M. The dose response of fentanyl in neonatal anesthesia. Anesthesiology 1987; 66 : 433–435. 51 Bokesch PM, Castaneda AR, Ziemer G et al. The influence of a right-to-left cardiac shunt on lidocaine pharmacokinetics. Anesthesiology 1987; 67 : 739–744. 52 Burrows FA, Lerman J, LeDez KM et al. Pharmacokinetics of lidocaine in children with congenital heart disease. Can J Anaesth 1991; 38 : 196–200. 53 Brown TC, Gregory M, Bell B et al. Response to nondepolarizing muscle relaxants in children with tumours. Anaesth Intens Care 1990; 18 : 460–465. 54 Bada HS, Khanna NN, Somani SM et al. Interconversion of theophylline and caffeine in newborn infants. J Pediatr 1979; 94 : 993–995. 55 Friis-Hansen B. Body water compartments in children: changes during growth and related changes in body composition. Pediatrics 1961; 28 : 169–181. 56 Meakin G, Walker RW, Dearlove OR. Myotonic and neuromuscular blocking effects of increased doses of suxamethonium in infants and children. Br J Anaesth 1990; 65 : 816–818. 57 Meakin G, McKiernan EP, Morris P et al. Dose–response curves for suxamethonium in neonates, infants and children. Br J Anaesth 1989; 62 : 655–658. 58 Fisher DM, O'Keeffe C, Stanski DR et al. Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology 1982; 57 : 203–208. 59 West JR, Smith HW, Chasis H. Glomerular filtration rate, effective renal blood flow, and maximal tubular excretory capacity in infancy. J Pediatr 1948; 32 : 10–18. 60 Meakin G, Morton RH, Wareham AC. Age-dependent variation in response to tubocurarine in the isolated rat diaphragm. Br J Anaesth 1992; 68 : 161–163. 61 Wareham AC, Morton RH, Meakin GH. Low quantal content of the endplate potential reduces safety factor for neuromuscular transmission in the diaphragm of the newborn rat. Br J Anaesth 1994; 72 : 205–209. 62 Stanski DR, Ham J, Miller RD et al. Pharmacokinetics and pharmacodynamics of d-tubocurarine during nitrous oxide-narcotic and halothane anesthesia in man. Anesthesiology 1979; 51 : 235–241. 63 Prys-Roberts C, Lloyd JW, Fisher A et al. Deliberate profound hypotension induced with halothane: studies of haemodynamics and pulmonary gas exchange. Br J Anaesth 1974; 46 : 105105. 64 Pauca AL, Hopkins AM. Acute effects of halothane, nitrous oxide and thiopentone on upper limb blood flow. Br J Anaesth 1972; 43 : 326–333. 65 Dutton GJ. Developmental aspects of drug conjugation with special reference to glucuronidation. Am Rev Pharmacol Toxicol 1978; 18 : 17–35. 66 McRorie TI, Lynn AM, Nespeca MK et al. The maturation of morphine clearance and metabolism. Am J Dis Child 1992; 146 : 972–976. 67 Way WL, Costley EC, Way EL. Respiratory sensitivity of the newborn infant to meperidine and morphine. Clin Pharmacol Ther 1965; 6 : 454–461. 68 Lynn AM, Nespeca MK, Opheim KE et al. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesth Analg 1993; 77 : 695–701. 69 Nichols DJ, Yaster M, Lynn AM et al. Disposition and respiratory effects of intrathecal morphine in children. Anesthesiology 1993; 79 : 733–738. 70 Hertzka RE, Gauntlett IS, Fisher DM. Fentanyl-induced ventilatory depression: effects of age. Anesthesiology 1989; 70 : 213–218. 71 Johnson KL, Erickson JP, Holley FO et al. Fentanyl pharmacokinetics in the pediatric population. Anesthesiology 1984; 61 : A441 A441. 72 Berde C. Convulsions associated with pediatric regional anesthesia. Anesth Analg 1992; 75 : 164–166. 73 Agarwal R, Gutlove DP, Lockhart CH. Seizures occurring in pediatric patients receiving continuous infusion of bupivacaine. Anesth Analg 1992; 75 : 284–286. 74 McCloskey JJ, Haun SE, Deshpande JK. Bupivacaine toxicity secondary to continuous caudal epidural infusion in children. Anesth Analg 1992; 75 : 287–290. 75 Mazoit JX, Denson DD, Samii K. Pharmacokinetics of bupivacaine following caudal anesthesia in infants. Anesthesiology 1988; 68 : 387–391. 76 Luz G, Innerhofer P, Bachmann B et al. Bupivacaine plasma concentrations during continuous epidural anesthesia in infants and children. Anesth Analg 1996; 82 : 231–234. 77 Luz G, Wieser C, Innerhofer P et al. Free and total bupivacaine plasma concentrations after continuous epidural anaesthesia in infants and children. Paed Anaesth 1998; 8 : 473–478. 78 Larsson BA, Lonnqvist PA, Olsson GL. Plasma concentrations of bupivacaine in neonates after continuous epidural infusion. Anesth Analg 1997; 84 : 501–505. 79 Tucker GT, Mather LE. Clinical pharmacokinetics of local anaesthetics. Clin Pharmacokinet 1979; 4 : 241–278. 80 Rowland M, Tozer TN. Clinical Pharmacokinetics: Concepts and Applications, 3rd edn. Baltimore: Williams & Wilkins; 1995. 81 Anderson BJ, Wollard GA, Holford NHG. A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. Br J Clin Pharmacol 2000; 50 : 125–134.DOI: 10.1046/j.1365-2125.2000.00231.x 82 Kearns GL, Leeder JS, Wasserman GS. Acetaminophen overdose with therapeutic intent. J Pediatr 1998; 132 : 5–8. 83 Heubi JE, Bien JP. Acetaminophen use in children: more is not better. J Pediatr 1997; 130 : 175–177. 84 Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 1998; 132 : 22–27. 85 Rivera Penera T, Gugig R, Davis J et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr 1997; 130 : 300–304. 86 Anderson BJ, Holford NHG, Armishaw JC et al. Predicting concentrations in children presenting with acetaminophen overdose. J Pediatrics 1999; 135 : 290–295. 87 Mohler CR, Nordt SP, Williams SR et al. Prospective evaluation of mild to moderate pediatric acetaminophen exposures. Ann Emerg Med 2000; 35 : 239–244. 88 Meakin G. Neonatal anaesthetic pharmacology. In: Hughes DG, Mather SJ, Wolf AR, eds. Handbook of Neonatal Anaesthesia. London: WB Saunders Co Ltd; 1996. 89 Eichler HG, Muller M. Drug distribution. The forgotten relative in clinical pharmacokinetics. Clin Pharmacokinet 1998; 34 : 95–99. 90 Henderson CJ, Bammler T, Wolf CR. Deduced amino acid sequence of a murine cytochrome P-450 Cyp4a protein: developmental and hormonal regulation in liver and kidney. Biochim Biophys Acta 1994; 1200 : 182–190. 91 Wilson JT. Identification of STH (somatostatin) as the hormone in a mixture of STH, ACTH and prolactin which decreased liver drug metabolism in the rat. Biochem Pharmacol 1969; 18 : 20292029. 92 Wilson JT. Alteration of normal development of drug metabolism by injection of growth hormone. Nature 1970; 225 : 861–863. 93 Wilson JT. Concomitant association between high plasma levels of growth hormone and low hepatic mixed-function oxidase activity in the youngest rat. J Pharm Exp Ther 1974; 189 : 225–270. 94 Buhler R, Lindros KO, Nordling A et al. Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur J Biochem 1992; 204 : 407–412. 95 Brazier JL, Salle B, Ribon B et al. In vivo N7 methylation of theophylline to caffeine in premature infants. Studies with use of stable isotopes. Dev Pharmacol Ther 1981; 2 : 137–144. 96 Alam SM, Roberts RJ, Fischer IJ. Age-related differences in salicylamide and acetaminophen conjugation in man. J Pediatr 1977; 90 : 130–135. 97 Holford NHG, Peck CC. Population pharmacodynamics and drug development. In: Van Boxtel CJ, Holford NHG, Danhof M, eds. The In Vivo Study of Drug Action. Amsterdam: Elsevier; 1992. 98 Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: part 2 – clinical use. Paed Anaesth 1997; 7 : 93–101. 99 Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: part 1 – pharmacokinetics. Paed Anaesth 1997; 7 : 5–11. 100 Inturrisi CE, Colburn WA. Application of pharmacokinetic-pharmacodynamic modeling to analgesia. In: Foley KM, Inturrisi CE, eds. Advances in Pain Research and Therapy Opioid Analgesics in the Management of Clinical Pain. New York: Raven Press, 1986: 441–452. 101 Dahlstrom B, Bolme P, Feychting H et al. Morphine kinetics in children. Clin Pharmacol Ther 1979; 26 : 354–365. 102 Levy G. Kinetics of drug action-an overview. In: van Boxtel CJ, Holford NHG, Danhof M, eds. The In Vivo Study of Drug Action, 1st edn. Amsterdam: Elsevier; 1992: xiii–xix. 103 McFarlan CS, Anderson BJ, Short TG. The use of propofol infusions in paediatric anaesthesia: a practical guide. Paed Anaesth 1999; 9 : 209–216. 104 Murat I, Billard V, Vernois J et al. Pharmacokinetics of propofol after a single dose in children aged 1–3 years with minor burns. Comparison of three data analysis approaches. Anesthesiology 1996; 84 : 526–532. 105 Schuttler J, Ihmsen H. Population pharmacokinetics of propofol: a multicenter study. Anesthesiology 2000; 92 : 727–738. 106 Cruze CA, Kelm GR, Meredith MP. Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology. Pharm Res 1995; 12 : 895–901. 107 Lave T, Schmitt Hoffmann AH, Coassolo P et al. A new extrapolation method from animals to man: application to a metabolized compound, mofarotene. Life Sci 1995; 56 : L473–L478. 108 Lave T, Dupin S, Schmitt C et al. Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. J Pharm Sci 1997; 86 : 584–590. 109 Paxton JW, Young D, Robertson IG. Pharmacokinetics of acridine-4-carboxamide in the rat, with extrapolation to humans. Cancer Chemother Pharmacol 1993; 32 : 323–325. 110 Anderson BJ, McKee AD, Holford NHG. Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. Clin Pharmacokinet 1997; 33 : 313–327. 111 Anderson BJ, Holford NHG, Woollard GA et al. Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol 1998; 46 : 237–243. 112 Anderson BJ, Holford NHG, Woollard GA et al. Perioperative pharmacodynamics of acetaminophen analgesia in children. Anesthesiology 1999; 90 : 411–421. 113 Grasela TH, Sheiner LB, Rambeck B et al. Steady-state pharmacokinetics of phenytoin from routinely collected patient data. Clin Pharmacokinet 1983; 8 : 355–364. 114 Anderson BJ, Holford NHG, Woollard GA. Aspects of theophylline clearance in children. Anaesth Intens Care 1997; 25 : 497–501. 115 Kenny GN. Target-controlled anaesthesia: concepts and first clinical experiences. Eur J Anaesthesiol Suppl 1997; 15 : 29–31. 116 Smith CE, Donati F, Bevan DR. Dose–response curves for succinylcholine; single versus cumulative techniques. Anesthesiology 1987; 67 : A358A358. 117 Pokela ML, Olkkola KT, Seppala T et al. Age-related morphine kinetics in infants. Dev Pharmacol Ther 1993; 20 : 26–34. 118 Stanski DR, Greenblatt DJ, Lowenstein E. Kinetics of intravenous and intramuscular morphine. Clin Pharmacol Ther 1978; 24 : 52–59. 119 Eyres RL, Bishop W, Oppenheim RC et al. Plasma bupivacaine concentrations in children during caudal epidural analgesia. Anaesth Intens Care 1983; 11 : 20–22. 120 Bosenberg AT, Bland BA, Schulte Steinberg O et al. Thoracic epidural anesthesia via caudal route in infants. Anesthesiology 1988; 69 : 265–269. 121 Baumgarten RK. Pharmacokinetic basis for local anesthetic infusions. Anesth Analg 1993; 77 : 13041304. 122 Marlow N, Weindling AM, Van Peer A et al. Alfentanil pharmacokinetics in preterm infants. Arch Dis Child 1990; 65 : 349–351. 123 Killian A, Davis PJ, Stiller RL et al. Influence of gestational age on pharmacokinetics of alfentanil in neonates. Dev Pharmacol Ther 1990; 15 : 82–85. 124 Davis PJ, Killian A, Stiller RL et al. Pharmacokinetics of alfentanil in newborn premature infants and older children. Dev Pharmacol Ther 1989; 13 : 21–27. 125 den Hollander JM, Hennis PJ, Burm AG et al. Alfentanil in infants and children with congenital heart defects. J Cardiothorac Anesth 1988; 2 : 12–17. 126 Rautiainen P. Alfentanil infusion for sedation in infants and small children during cardiac catheterization. Can J Anaesth 1991; 38 : 980–984. 127 Goresky GV, Koren G, Sabourin MA et al. The pharmacokinetics of alfentanil in children. Anesthesiology 1987; 67 : 654–659. 128 Roure P, Jean N, Leclerc AC et al. Pharmacokinetics of alfentanil in children undergoing surgery. Br J Anaesth 1987; 59 : 1437–1440. 129 Meistelman C, Saint Maurice C, Lepaul M et al. A comparison of alfentanil pharmacokinetics in children and adults. Anesthesiology 1987; 66 : 13–16. 130 Bower S, Hull CJ. Comparative pharmacokinetics of fentanyl and alfentanil. Br J Anaesth 1982; 54 : 871–877. 131 Bovill JG, Sebel PS, Blackburn CL et al. The pharmacokinetics of alfentanil (R39209): a new opioid analgesic. Anesthesiology 1982; 57 : 439–443. 132 Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240 : 159–166. 133 Persson MP, Nilsson A, Hartvig P. Pharmacokinetics of alfentanil in total i.v. anaesthesia. Br J Anaesth 1988; 60 : 755–761. 134 van den Nieuwenhuyzen MC, Engbers FH, Burm AG et al. Computer-controlled infusion of alfentanil for postoperative analgesia. A pharmacokinetic and pharmacodynamic evaluation. Anesthesiology 1993; 79 : 481–492. 135 Hudson RJ, Thomson IR, Burgess PM et al. Alfentanil pharmacokinetics in patients undergoing abdominal aortic surgery. Can J Anaesth 1991; 38 : 61–67. 136 Brody S. Relativity of physiological time and physiological weight. Growth 1937; 1 : 60–67. 137 Carrel A. Physiological time. Science 1931; 74 : 618–621. 138 Weiss M. Dependence of pharmacokinetic parameters on the body weight. Int J Clin Pharmacol 1977; 15 : 572–575. Citing Literature Volume12, Issue3March 2002Pages 205-219 ReferencesRelatedInformation
Referência(s)